 |
Levocarnitine |
|---|---|
| Trade Name | Carnitor |
| Orphan Indication | For the treatment of secondary carnitine deficiency in valproic acid toxicity |
| USA Market Approval | USA |
| USA Designation Date | 1989-11-15 00:00:00 |
| Sponsor | Sigma-Tau Pharmaceuticals, Inc.;9841 Washingtonian Blvd, Suite500;Gaithersburg, MD, 20878 |
